WOLVERINE
WOLVERINE combines BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 synthetic fragment) β two of the most widely studied regenerative peptides in preclinical literature, targeting complementary tissue repair pathways.
BPC-157 is a 15-amino acid peptide studied for angiogenesis, NO pathway activation, and systemic healing across multiple tissue types. TB-500 is a Thymosin Beta-4 fragment that regulates actin polymerization, cellular migration, and wound healing. Their combination addresses both vascular and structural repair.
Add 2mL bacteriostatic water to the vial (10mg total β 5mg BPC-157 + 5mg TB-500). Inject along the inner vial wall and swirl gently. Refrigerate after reconstitution; use within 28 days.
Verified Before it Reaches You.
Every Genix batch undergoes independent third-party testing. The CoA for this product is batch-specific β issued by the testing laboratory, not generated by Genix.
Research Grade Β· 99% Purity
Frequently Paired With
Researchers often combine WOLVERINE with these compounds for multi-target protocols.
Frequently Asked Questions
WOLVERINE is a dual-peptide research blend containing BPC-157 and TB-500. Both are extensively studied in preclinical research for tissue repair, angiogenesis, and regenerative mechanisms targeting complementary recovery pathways.
BPC-157 works through the NO system and angiogenesis pathways. TB-500 regulates actin binding and cellular migration. Together they address multiple aspects of tissue repair that either peptide alone does not fully cover in research models.
Store lyophilized at 2β8Β°C. Once reconstituted with bacteriostatic water, refrigerate and use within 28 days. Protect from direct light and moisture.
No. All Genix compounds are strictly for in vitro research and laboratory use only. Not for human or veterinary consumption.